VAV3 Polyklonaler Antikörper
VAV3 Polyklonal Antikörper für WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA
Wirt / Isotyp
Kaninchen / IgG
Getestete Reaktivität
human
Anwendung
WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA
Konjugation
Unkonjugiert
Kat-Nr. : 30291-1-PBS
Synonyme
Geprüfte Anwendungen
Produktinformation
30291-1-PBS bindet in WB, IHC, IF/ICC, FC (Intra), IP, Indirect ELISA VAV3 und zeigt Reaktivität mit human
| Getestete Reaktivität | human |
| Wirt / Isotyp | Kaninchen / IgG |
| Klonalität | Polyklonal |
| Typ | Antikörper |
| Immunogen | VAV3 fusion protein Ag33022 |
| Vollständiger Name | vav 3 guanine nucleotide exchange factor |
| Berechnetes Molekulargewicht | 98kd |
| Beobachtetes Molekulargewicht | 98 kDa |
| GenBank-Zugangsnummer | NM_006113 |
| Gene symbol | VAV3 |
| Gene ID (NCBI) | 10451 |
| Konjugation | Unkonjugiert |
| Form | Liquid |
| Reinigungsmethode | Antigen-Affinitätsreinigung |
| Lagerungspuffer | PBS only |
| Lagerungsbedingungen | Store at -80°C. 20ul Größen enthalten 0,1% BSA. |
Hintergrundinformationen
Vav3, a member of Dbl family which is also the activator of GTP kinase of Rho family, can activate the expression of RhoA, Racl and Cdc42 (PMID:28285969). Vav3 is associated with tumor growth, apoptosis, invasion, metastasis and angiogenesis (PMID:28285969). Vav3 is a multiple function protein with both signaling molecule and coactivator activities. Vav3 oncogene is overexpressed in androgen-independent prostate cancer cells relative to their androgen-dependent counterparts and contribute to development of hormone refractory prostate cancer (PMID:21455584).











